Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rofil Medical was a Dutch medical device company specializing in products for aesthetic and reconstructive surgery. The company's flagship product was Artecoll, a permanent dermal filler consisting of polymethylmethacrylate (PMMA) microspheres suspended in a collagen solution. Rofil Medical also distributed breast implants under the brand name M-implants, which were later revealed to be manufactured by the disgraced French firm Poly Implant Prothèse (PIP). Due to the fallout from the PIP scandal and other regulatory hurdles, the company declared bankruptcy in 2009 and is no longer active. Its PMMA filler technology eventually became the basis for Bellafill in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rofil Medical.